Arshad M. Khanani

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial

Arshad M. Khanani, Samantha Xavier, Edward Ysasaga · The Lancet · 2023 · 315 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +4

Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema

Jayashree Sahni, Sunil Patel, Pravin U. Dugel et al. · Ophthalmology · 2019 · 272 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration

Arshad M. Khanani, Sunil Patel, Philip J. Ferrone et al. · JAMA Ophthalmology · 2020 · 180 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

TENAYA and LUCERNE

Arshad M. Khanani, Aachal Kotecha, Andrew Chang et al. · Ophthalmology · 2024 · 179 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +17

The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results

Arshad M. Khanani, Aamir Aziz, Hannah Khan et al. · Eye · 2023 · 167 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +8